Skip to content

To evaluate the efficacy and safety of digital therapy for tele-rehabilitation in patients with acute coronary syndrome after percutaneous coronary intervention: a single-center, prospective, open-label, randomized controlled clinical study

To evaluate the efficacy and safety of digital therapy for tele-rehabilitation in patients with acute coronary syndrome after percutaneous coronary intervention: a single-center, prospective, open-label, randomized controlled clinical study

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071318
Enrollment
Unknown
Registered
2023-05-11
Start date
2023-05-15
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

experimental group:According to the digital theraputics App to guide the post-operative rehabilitation exercise
control group:Routine post-operative rehabilitation exercise

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. male or female, 18 to 75 years old 2. After percutaneous coronary intervention therapy due to a clinically definitive diagnosis of acute coronary syndromes (including exertional angina, ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction). 3. Be agree to sign an informed consent form and be able to cooperate with the hospital to collect relevant indicator information regularly after discharge

Exclusion criteria

Exclusion criteria: 1. Non-coronary atherosclerotic cardiological ischemia 2. New York College of Cardiology (NYHA) Cardiac Function Grade III-IV or Gillip Grade III-IV Congestive Heart Failure 3. Other serious systemic diseases such as HIV infection, malignant tumors, severe liver and kidney primary diseases and chronic lung diseases 4. Clinical conditions with a combined life expectancy < 12 months, or not all follow-up can be completed 5. Cannot exercise 6. Participate in other interventional clinical studies at the time of admission or within 30 days prior to admission 7. Other situations in which the researcher deems it inappropriate to join the group 8. Unwillingness to sign written informed consent or to follow a research protocol

Design outcomes

Primary

MeasureTime frame
Cardio Pulmonary Exercise Testing: AT, VO2Max;

Secondary

MeasureTime frame
distance of the six-minute walk test;quality of life survey;Heart rhythm analysis;Compliance: Completion of each rehabilitation exercise = Completion time / set time;

Countries

China

Contacts

Public ContactYawei Xu

Shanghai Tenth People's Hospital

xx@mvtech.cc+86 189 1768 4941

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026